Procainamide Hydrochloride
Who holds supplier records for Procainamide Hydrochloride? 4 organisations hold a current record for Procainamide Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Taiwan (1) and United States (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Procainamide Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/procainamide-hydrochloride
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Procainamide Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaCEPActive DMF 33216 · latest filing Sept 2018
- CHENG FONG CHEMICAL CO LTDTaiwanActive DMF 25461 · latest filing Oct 2011
- GLAND PHARMA LTDIndia Company GMP cert on recordActive DMF 36402 · latest filing Oct 2021
- W R GRACE AND CO -CONNUnited StatesActive DMF 4911 · latest filing Apr 1983
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (1)
Certificates of Suitability on the EDQM register for Procainamide Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 2 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED Hyderabad | IN | CEP 2019-119 - Rev 03 Procainamide Hydrochloride | Sept 2026 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Procainamide Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- HOECHST AGInactive DMF 3410 · filed Dec 1978
- GANES CHEMICALS INC PENNSVILLE DIVInactive DMF 2133 · filed Jul 1973
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Procainamide Hydrochloride is an antiarrhythmic medication used to treat and maintain the normal rhythm of the heart. It works by blocking certain electrical signals in the heart that can cause an irregular heartbeat.
Chemical identity
- IUPAC name
- 4-amino-N-[2-(diethylamino)ethyl]benzamide;hydrochloride
- Canonical SMILES
- CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl
- InChIKey
- ABTXGJFUQRCPNH-UHFFFAOYSA-N
- Synonyms
- Pronestyl API, amidoprocaine, cardiorytmin, nsc-757279, procainamide hcl, procainamidi hydrochloridum, procan, procan sr, procanbid, procapan, pronestyl
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Antiarrhythmic
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Procainamide Hydrochloride?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Procainamide Hydrochloride: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), CHENG FONG CHEMICAL CO LTD (Taiwan), GLAND PHARMA LTD (India) and W R GRACE AND CO -CONN (United States). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Procainamide Hydrochloride Drug Master Files are active?
BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 33216), CHENG FONG CHEMICAL CO LTD (DMF 25461), GLAND PHARMA LTD (DMF 36402) and W R GRACE AND CO -CONN (DMF 4911). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Procainamide Hydrochloride records mean?
2 organisations have only inactive Type II DMFs for Procainamide Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Procainamide Hydrochloride have a European Certificate of Suitability?
Yes. 1 organisation holds a valid CEP for Procainamide Hydrochloride on the EDQM register, including BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED Hyderabad (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Procainamide Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Procainamide Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.